List of insiders holdings for LadRx Corp:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | KRIEGSMAN STEVEN A Chief Executive Officer |
2020-08-13 18:43:12 | 3,668,038 0 |
3,668,038 | Form 4 |
2 | Patterson Scott Bradford 10% Owner |
2016-12-27 14:25:54 | 3,160,653 0 |
3,160,653 | Form 13G |
3 | Brien Earl W Director |
2020-08-20 06:10:24 | 890,247 0 |
890,247 | Form 4 |
4 | IGNARRO LOUIS Director |
2020-08-13 18:41:59 | 600,785 0 |
600,785 | Form 4 |
5 | LEVITT DANIEL J EVP and Chief Medical Officer |
2016-12-19 14:32:19 | 400,000 0 |
400,000 | Form 4 |
6 | Barber Jack R Chief Scientific Officer |
2009-07-06 15:28:42 | 400,000 0 |
400,000 | Form 4 |
7 | CAPPELLO ALEXANDER L Director |
2003-10-17 20:01:51 | 374,747 0 |
374,747 | Form 4 |
8 | Ware Olivia C Chief Commercial Officer |
2016-01-14 18:28:41 | 350,000 0 |
350,000 | Form 4 |
9 | Levin Ben SVP-Legal Affairs/GC/Secy |
2015-12-17 12:56:32 | 300,000 0 |
300,000 | Form 4 |
10 | PEACOCK KIRK Chief Financial Officer |
2003-08-27 14:45:15 | 210,000 0 |
210,000 | Form 3 |
11 | Geyer David Scott Sr. V.P. of Manufacturing |
2011-12-13 19:32:33 | 200,000 0 |
200,000 | Form 4 |
12 | LINK MAX Director |
2013-12-12 16:57:42 | 180,000 0 |
180,000 | Form 4 |
13 | SELTER MARVIN R Director |
2013-12-12 17:52:10 | 180,000 0 |
180,000 | Form 4 |
14 | Wennekamp Richard L. Director |
2014-12-16 17:35:17 | 180,000 0 |
180,000 | Form 4 |
15 | Cohen Cheryl Director |
2015-12-17 12:53:01 | 180,000 0 |
180,000 | Form 4 |
16 | SELTER ERIC JAY Director |
2015-12-17 13:00:02 | 180,000 0 |
180,000 | Form 4 |
17 | Chawla Anita J Director |
2016-12-19 12:35:11 | 180,000 0 |
180,000 | Form 4 |
18 | RUBINFELD JOSEPH Director |
2016-12-19 12:59:57 | 180,000 0 |
180,000 | Form 4 |
19 | LIBERMAN GREGORY R General Cnsel & Corp Secretay |
2004-01-14 13:13:32 | 175,000 0 |
175,000 | Form 3 |
20 | Tepper Mark Vice President |
2007-05-10 12:55:27 | 175,000 0 |
175,000 | Form 4 |
21 | SHAH JAISIM Sr. VP - Business Development |
2009-05-05 15:43:17 | 150,000 0 |
150,000 | Form 3 |
22 | Wieland Douglas Scott Sr VP - Drug Development |
2016-12-19 14:27:02 | 150,000 0 |
150,000 | Form 4 |
23 | Chawla Shanta M.D. Senior VP-Drug Development |
2017-06-20 18:33:01 | 122,100 0 |
122,100 | Form 3 |
24 | FOGELMAN MITCHELL K Chief Financial Officer |
2008-11-24 20:37:46 | 100,000 0 |
100,000 | Form 4 |
25 | Ng Shi Chung Sr VP Research & Development |
2008-11-24 20:02:12 | 50,000 0 |
50,000 | Form 4 |
26 | Natalizio Matt Chief Financial Officer |
2006-06-21 17:23:21 | 50,000 0 |
50,000 | Form 4 |
27 | Kratz Felix Vice President Drug Discovery |
2018-01-02 17:27:24 | 25,000 0 |
25,000 | Form 4 |
28 | Snowdy Stephen Chief Executive Officer |
2024-01-29 16:05:14 | 25,000 0 |
25,000 | Form 4 |
29 | CARNAHAN RAYMOND C JR Director until 10-10-2003 Director |
2003-10-17 17:53:11 | 20,000 0 |
20,000 | Form 4/A |
30 | MCDADE HERBERT H JR Director until 10-10-2003 Director |
2003-10-17 18:16:22 | 20,000 0 |
20,000 | Form 4 |
31 | CALOZ JOHN Y Chief Financial Officer |
2024-01-29 16:05:19 | 15,000 0 |
15,000 | Form 4 |
32 | Simpson Jennifer K. Director |
2024-01-29 16:05:23 | 5,000 0 |
5,000 | Form 4 |
33 | Claiborne Cary J Director |
2024-01-29 16:06:09 | 5,000 0 |
5,000 | Form 4 |
34 | Caldwell Joel K Director |
2024-01-29 16:06:16 | 5,000 0 |
5,000 | Form 4 |
35 | Curtis Eric Pres., Chief Operating Officer |
2018-05-21 16:25:49 | 0 0 |
0 | Form 3 |